Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Delfen 12.5% contraceptive foam
0703030G0BCABAE
|
Delfen | Nonoxinol 9 | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Delgocitinib 20mg/g cream
1305030M0AAAAAA
|
Delgocitinib | Delgocitinib | Skin | No data available |
|
Delph aftersun gel
190205500BCPPA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Delph aftersun lotion
190205500BCPNA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Delph sun lotion SPF 15
130801000BBLGA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Delph sun lotion SPF 20
130801000BBLNA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Delph sun lotion SPF 25
130801000BBLJA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Delstrigo 100mg/300mg/245mg tablets
0503010ASBBAAAA
|
Delstrigo | Doravirine/lamivudine/tenofovir disoproxil | Infections | No data available |
|
Deltastab 25mg/1ml suspension for injection ampoules
1001022N0BBABAB
|
Deltastab (Parenteral) | Prednisolone acetate | Musculoskeletal and Joint Diseases | No data available |
|
Deltyba 50mg tablets
0501090W0BBAAAA
|
Deltyba | Delamanid | Infections | No data available |
|
Demeclocycline 150mg tablets
0501030F0AAAIAI
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | No data available |
|
Demeclocycline 150mg/5ml oral liquid
0501030F0AAAGAG
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | No data available |
|
Demeclocycline 300mg/5ml oral liquid
0501030F0AAAFAF
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | No data available |
|
Demeclocycline 75mg/5ml oral liquid
0501030F0AAAHAH
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | No data available |
|
Demix 100 capsules
0501030I0BHAAAB
|
Demix | Doxycycline hyclate | Infections | No data available |
|
Demix 50 capsules
0501030I0BHABAA
|
Demix | Doxycycline hyclate | Infections | No data available |
|
Demorem 4mg/5ml oral solution
0406000S0BDAAAG
|
Demorem | Ondansetron hydrochloride | Central Nervous System | No data available |
|
Dengue tetravalent vacc (live, attenuated) inj 0.5ml pfs
1404000AVAAAAAA
|
Dengue vaccine | Dengue fever | Immunological Products and Vaccines | No data available |
|
Dental Pain Relief tablets
0407010N0BEABAJ
|
Boots (co-dydramol) | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | No data available |
|
Dentogen Clove Oil 20% dental gel
120304000BBCRBD
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Dentogen Clove Oil 50% dental liquid
120304000BBDAA0
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Dentomycin 2% dental gel
1203020P0BBAAAA
|
Dentomycin | Minocycline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Denzapine 200mg tablets
0402010C0BCADAD
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
Denzapine 50mg/ml oral suspension
0402010C0BCAEAE
|
Denzapine | Clozapine | Central Nervous System | No data available |
|
DeOdour neutralising sachets
23450454500
|
DeOdour neutralising sachets | Deodorants | Stoma Appliances | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.